|
Post by babaoriley on Nov 18, 2017 13:08:12 GMT -5
The issuance of the shares do not define when or how they will be used. It comes down to a belief like god. Do you like where the company is heading or do you oppose it. Do you believe in the management's decisions or don't You? Without the ATM which creates tremendous freedom for the board to now demonstrate in front of a large scale audiences the advantages of inhaling rather than injecting is an individual call. I know that Afrezza is THE test drug for Technosphere and believe with enough exposure and media buzz along with other catalysts Afrezza will be successful. If Afrezza is successful then Technospere will be successful. Mannkind is now incharge of it's own destiny. If this were a game of poker my hand feels very strong and though I have been challenged with doubt with little confidence at times because it has been beaten down by Giants; Afrezza will ultimately be recognized for it's superiority. I Like our Management. The advertisements being shown in sections of the country which were promised by management have demonstrates their deserved trust. They also stated that Scripts would increase in the 4th Q. I expect that to be proven true as well if advertising has affect; as I expect it will. Unshackled Representatives dedicated to one drug speaking to physicians by allowance of New FDA Label change FREES them up to deliver a more accurate picture to promote sales. Things look very Good to me. I feel the company MNKD has a very talented group of people turning this company around. In that I support their efforts I will be voting my shares a clear YES. I'd rather have MNKD have enough to manifest the goal of delivering Alfred Mann's Afrezza to a global level which will give this company the respect it deserves for it's scientific superiority with no needles. This can be a reality. Our singular drug; Our distribution Contacts... No other Corporations playing us. This is our game now And I have a great hand and have more than doubled down since the 1 for 5 split. The potential remains what it was before the hurdles which was/is Amazon/Google as I perceive it ... it seems like we are moving closer and closer to sustaining our selves with # of scripts and price increase. This is no time to bind the hands of Mannkind Management. A vote Yes; once again doesn't not mean that all the shares be used; only that the shares be available as a tool for negotiation and time necessary to market. It eliminates the question in physicians minds if the company will be around to deliver what Exubra could not. Afrezza is Human Insulin EXACTLY like the stuff a Healthy Human Pancreas makes. This is Life Changing. This is money Making. I've made my bet and seen this company stand up to many challenges.. let's watch it cross the finish line. In the face of human suffering Mannkind will deliver relief for a huge population. An investment in Humanity is noble ambition and now attainable. The Victor Laszlow Award winner!!! Congrats, the kindaguyiyam! Mango, your post just prior was a worthy second place finisher! "Welcome back to the fight. This time, I know our side will win."
|
|
|
Post by slugworth008 on Nov 18, 2017 13:55:05 GMT -5
The issuance of the shares do not define when or how they will be used. It comes down to a belief like god. Do you like where the company is heading or do you oppose it. Do you believe in the management's decisions or don't You? Without the ATM which creates tremendous freedom for the board to now demonstrate in front of a large scale audiences the advantages of inhaling rather than injecting is an individual call. I know that Afrezza is THE test drug for Technosphere and believe with enough exposure and media buzz along with other catalysts Afrezza will be successful. If Afrezza is successful then Technospere will be successful. Mannkind is now incharge of it's own destiny. If this were a game of poker my hand feels very strong and though I have been challenged with doubt with little confidence at times because it has been beaten down by Giants; Afrezza will ultimately be recognized for it's superiority. I Like our Management. The advertisements being shown in sections of the country which were promised by management have demonstrates their deserved trust. They also stated that Scripts would increase in the 4th Q. I expect that to be proven true as well if advertising has affect; as I expect it will. Unshackled Representatives dedicated to one drug speaking to physicians by allowance of New FDA Label change FREES them up to deliver a more accurate picture to promote sales. Things look very Good to me. I feel the company MNKD has a very talented group of people turning this company around. In that I support their efforts I will be voting my shares a clear YES. I'd rather have MNKD have enough to manifest the goal of delivering Alfred Mann's Afrezza to a global level which will give this company the respect it deserves for it's scientific superiority with no needles. This can be a reality. Our singular drug; Our distribution Contacts... No other Corporations playing us. This is our game now And I have a great hand and have more than doubled down since the 1 for 5 split. The potential remains what it was before the hurdles which was/is Amazon/Google as I perceive it ... it seems like we are moving closer and closer to sustaining our selves with # of scripts and price increase. This is no time to bind the hands of Mannkind Management. A vote Yes; once again doesn't not mean that all the shares be used; only that the shares be available as a tool for negotiation and time necessary to market. It eliminates the question in physicians minds if the company will be around to deliver what Exubra could not. Afrezza is Human Insulin EXACTLY like the stuff a Healthy Human Pancreas makes. This is Life Changing. This is money Making. I've made my bet and seen this company stand up to many challenges.. let's watch it cross the finish line. In the face of human suffering Mannkind will deliver relief for a huge population. An investment in Humanity is noble ambition and now attainable. Outstanding post. Well said.
|
|
|
Post by rockstarrick on Nov 18, 2017 16:28:52 GMT -5
They have 8.8M shares, so they sold 13.3M shares. From the filing, As of the date of this proxy statement, the Company was not aware of any beneficial owner of more than five percent of its common stock other than The Mann Group LLC and The Alfred E. Mann Living Trust. The Mann Group, 7.4% of the Company or 8.6 million shares, The Alfred Mann Living Trust, 7.5% of the Company or 8.8 million shares I believe I am reading this right. I'm voting yes in 3 different accounts, but this does add up to just over 17 million, right ?? Read more: mnkd.proboards.com/thread/9088/special-vote-held-on-12?page=3#ixzz4yowDZpFP
|
|
|
Post by thekindaguyiyam on Nov 18, 2017 17:03:48 GMT -5
thanks baba. humble and proud to accept it. thanks to all. I'd kill for a nobel peace prize. But the Laszlo is a close 2nd. www.youtube.com/watch?v=kOO9GsiMb1g good to find myself surrounded with others who have shared the same journey and have an understanding of how big this can be.
|
|
|
Post by xanet on Nov 18, 2017 17:47:26 GMT -5
They have 8.8M shares, so they sold 13.3M shares. From the filing, As of the date of this proxy statement, the Company was not aware of any beneficial owner of more than five percent of its common stock other than The Mann Group LLC and The Alfred E. Mann Living Trust. The Mann Group, 7.4% of the Company or 8.6 million shares, The Alfred Mann Living Trust, 7.5% of the Company or 8.8 million shares I believe I am reading this right. I'm voting yes in 3 different accounts, but this does add up to just over 17 million, right ?? Read more: mnkd.proboards.com/thread/9088/special-vote-held-on-12?page=3#ixzz4yowDZpFPDid you read the footnotes?
|
|
|
Post by mnholdem on Nov 18, 2017 18:30:08 GMT -5
They have 8.8M shares, so they sold 13.3M shares. From the filing, As of the date of this proxy statement, the Company was not aware of any beneficial owner of more than five percent of its common stock other than The Mann Group LLC and The Alfred E. Mann Living Trust. The Mann Group, 7.4% of the Company or 8.6 million shares, The Alfred Mann Living Trust, 7.5% of the Company or 8.8 million shares I believe I am reading this right. I'm voting yes in 3 different accounts, but this does add up to just over 17 million, right ?? Read more: mnkd.proboards.com/thread/9088/special-vote-held-on-12?page=3#ixzz4yowDZpFP www.sec.gov/Archives/edgar/data/1678728/000120919117034778/xslF345X03/doc3.xmlAlthough there are 8,398,187 shares held directly, there's another 17,930,450 shares (post-split) held indirectly by the Alfred E. Mann Living Trust. Another 12 million are indirectly owned by Biomed Partners, for which the AEM Living Trust is the managing member, as well as Mannco LLC. This disclosure was filed shortly after Al's death and there are no more recent transactions which I think that lawyers for the AEMLT would had to have filed with the SEC* if the trust had sold shares. One thing I wonder is whether the trust allowed Al's Stock Options (Right to Buy) to expire on 08/26/2017. Footnote 6 states that these Options became immediately exercisable upon his death --- * SEC Requirement Schedule 13DSchedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities registered under Section 12 of the Securities Exchange Act of 1934, they are required to file a Schedule 13D with the SEC. (Depending upon the facts and circumstances, the person or group of persons may be eligible to file the more abbreviated Schedule 13G in lieu of Schedule 13D.)
Schedule 13D reports the acquisition and other information within ten days after the purchase. The schedule is filed with the SEC and is provided to the company that issued the securities and each exchange where the security is traded. Any material changes in the facts contained in the schedule require a prompt amendment. The schedule is often filed in connection with a tender offer.Source: www.sec.gov/fast-answers/answerssched13htm.html--- It seems to me that if the Alfred E. Mann Living Trust have sold any shares since their last filing, their lawyers would have had to notify the SEC within ten days. The submittal made shortly after Al Mann's death (link above) appears to be the most recent filing. If the trust chose to let the Options-to-Buy expire in August, they would not be required to file, since no transaction transpired.
|
|
|
Post by xanet on Nov 18, 2017 19:07:04 GMT -5
From the filing, As of the date of this proxy statement, the Company was not aware of any beneficial owner of more than five percent of its common stock other than The Mann Group LLC and The Alfred E. Mann Living Trust. The Mann Group, 7.4% of the Company or 8.6 million shares, The Alfred Mann Living Trust, 7.5% of the Company or 8.8 million shares I believe I am reading this right. I'm voting yes in 3 different accounts, but this does add up to just over 17 million, right ?? Read more: mnkd.proboards.com/thread/9088/special-vote-held-on-12?page=3#ixzz4yowDZpFP www.sec.gov/Archives/edgar/data/1678728/000120919117034778/xslF345X03/doc3.xmlAlthough there are 8,398,187 shares held directly, there's another 17,930,450 shares (post-split) held indirectly by the Alfred E. Mann Living Trust. Another 12 million are indirectly owned by Biomed Partners, for which the AEM Living Trust is the managing member, as well as Mannco LLC.I don't know if that's right. Those amounts are over 5%, so wouldn't those shares show up in the list MannKind gave? I think that information is old, unless I'm missing something.
|
|
|
Post by rockstarrick on Nov 18, 2017 20:50:27 GMT -5
I don't know if that's right. Those amounts are over 5%, so wouldn't those shares show up in the list MannKind gave? I think that information is old, unless I'm missing something. That list is where I got the numbers, it is confusing, but I'm thinking Mannkind just wanted to cover the 30 million tapped by the Company. Good Luck Xanet 🍀
|
|
|
Post by rockstarrick on Nov 18, 2017 20:53:29 GMT -5
I don't know if that's right. Those amounts are over 5%, so wouldn't those shares show up in the list MannKind gave? I think that information is old, unless I'm missing something. From the list The Mann Group LLC(1) 8,621,942 7.4 % 12744 San Fernando Road Sylmar, CA 91342 The Alfred E. Mann Living Trust(2) 8,806,500 7.5 % 12744 San Fernando Road Sylmar, CA 91342 Read more: mnkd.proboards.com/thread/9088/special-vote-held-on-12?page=3#ixzz4yq2nzmAv
|
|
|
Post by mnholdem on Nov 18, 2017 21:07:08 GMT -5
So, somebody help me here...is there a way the Alfred E. Mann Living Trust would be allowed to report their holdings annually rather than within the ten day reporting period required by the SEC for beneficial owners of more than 5% outstanding shares? Otherwise, it would seem that the Trust is in violation of SEC reporting requirements. It's a mystery all right. I found myself wondering if the discrepancy may be caused by MannKind tapping into the ATM after the 3rd Quarter to the tune of 9 million shares, which wouldn't get reported until the February EOY earnings call, but then I realized than the ATM is with the Mann Group rather than the AEM Living Trust. Any ideas on why there's no filing if shares were sold?
|
|
|
Post by lakers on Nov 18, 2017 21:15:45 GMT -5
These purposes may include: raising capital; providing equity incentives to employees, officers and directors; establishing strategic relationships with other companies; conversion of debt; expanding business or product lines through the acquisition of other businesses or products; and other purposes. The additional shares of common stock that would become available for issuance if the proposal is adopted could also be used by the Company to oppose a hostile takeover attempt or to delay or prevent changes in control or management of the Company. For example, without further stockholder approval, the Board could strategically sell shares of common stock in a private transaction to purchasers who would oppose a takeover or favor the current Board. Although this proposal to increase the authorized common stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at the Company), stockholders should be aware that approval of the proposal could facilitate future efforts by the Company to deter or prevent changes in control of the Company, including transactions in which the stockholders might otherwise receive a premium for their shares over then current market prices. seekingalpha.com/filing/3771686I have never seen more details on Poison Pill provision than the biz usage of stock for such a 100% dilution. Isn't that obvious? Note that the BoD, mgmt don't ask for an incremental amount but an outright chunk to fend off something?
|
|
|
Post by winner on Nov 19, 2017 6:29:53 GMT -5
Count me in for a resounding yes vote. In fact, as soon as the shares are approved, I will be purchasing 3000 more shares.
|
|
|
Post by sla55 on Nov 19, 2017 9:36:31 GMT -5
I would like Mike to schedule an investor call for him to talk about this for more than 30 seconds... tell us in broad strokes why he thinks doubling the shares is prudent (with all the normal "forward looking" disclaimers), and actually ask for our trust in him and the BoD. If he believes (as some here seem to) that there is little chance of the full 140M ever being used, let him state that... at least then I could judge his performance against that. Tell us a range of what he expects to use... how many will go into employee stock incentives... etc. " The purpose of the 140 million --- there is no right or wrong number. You could have went for 20 million. you could have went for 200 million. There are 140 million outstanding shares now, so we're just increasing that count to 280 million. The reality is that if you want to make an acquisition, you have to have shares. If you want to continue to expand the company, you might need shares available to do things. To do partnerships, you could need shares, to bring in an ownership in the company.So we only have 4 million shares left. That's not in the interest of shareholders to run a company and have zero options on the table if things pop up over the next two to three years. So what I didn't want to do, honestly, is say I want 20 million shares and everybody says, "Oh, we have 10% dilution coming." You needed to have a number that was reasonable but not too absurd. I think that's what's important.We think we're doing the prudent thing by asking for more than we need. Over the next three to five years, we should put those shares to good use. When you think about 140 million, we don't need all those shares tomorrow. That's a misperception a lot of people have." - Michael Castagna
|
|
|
Post by akemp3000 on Nov 19, 2017 10:08:26 GMT -5
Thanks sla. Mike C's explanation "should" put this issue to rest. Realists, whether short or long, know the shares are going to be authorized. Even this MB poll indicates most shareholders support Mike's strategic plan. Based on his comments, there won't be any near-term dilution unless it comes in a package that also includes a new partner, part owner, an increase in marketing or something else with a positive net result. Mike C has made a lot of good decisions since becoming CEO. This is the latest.
|
|
|
Post by lakers on Nov 19, 2017 14:11:32 GMT -5
"To do partnerships, you could need shares, to bring in an ownership in the company."
I have said there would be no serious partnership unless that includes an ownership of the company. Check Shark Tank deals. Next on check list is international partnership. I expect 5, 10% equity stake granted at a fixed price > $6 Pps. That should put a floor under pps.
Nate could be right by saying pps could back down to $3.50 before rebounding to $9, $10. 10M share stake at $10 raising $100M is possible for each following partner. We can raise $300M to fund ops for the next 2.5yrs with continuous TV campaign which should help reach $120M annual break even rev much faster.
UAE+Saudi Arabia+Oman+India Can+Mex China
Sny deal mistake was not allowing Sny to invest in Mnkd for 10% (50 M shares) at $10 pps pre-split. That would have raised $0.5 B and kept Sny honest irrespective of regime change. Rest assured that BoD won't make the same mistake again. Al was too confident and concerned about dilution perhaps.
That said, I expect a partnership announcement before 1/15/18. It's long overdue. IMHO, mgmt is cognizant of that lest they lose credibility for alluding to that for a year already. So far, MC has achieved everything he set out to do in the list. The huge short will fuel the rocket launch as we witnessed the 4x rise in 4 weeks.
|
|